Categories: aggregated

DEA Hit with Another Marijuana Lawsuit Yet Again

It’s no secret that the only cannabis available for official use on research is provided by the University of Mississippi and NIDA, which is notoriously low in quality. The lawsuit also states that this marijuana is unfit for research because of “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.” What makes it worse is that this cannabis is only allowed for research and not to be sold commercially, which means that it can’t be used for Phase 3 studies of the FDA, required under the Good Manufacturing Processes.

Jason

Share
Published by
Jason

Recent Posts

Medical Cannabis in 2026: What 500+ Studies Proved for Pain, Dementia & Sleep

The heavyweight is a network meta-analysis of 28 randomized controlled trials covering 3,058 adults, which…

12 hours ago

Will Texas Legalize Weed in 2027? What the Blue Wave Means for Cannabis in the Lone Star State

So, will Texas legalize? Maybe not in 2027. But the people who blocked it are…

3 days ago

AI Data Centers Are Taking Over Cannabis Farms—And Why You Might Need to Grow Your Own Weed

Struggling cannabis farms are eyeing a second life as data centers. The grow room you…

4 days ago

A Beginner’s Guide to Low-Dose Social Drinking

Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…

7 days ago

6 Surprising Truths Cannabis Actually Teaches You About Yourself

A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…

1 week ago

DEA Hearing Bombshell: Marijuana Rescheduling Rules Never Existed

Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…

1 week ago